SCM
RGDX

Summit Capital Management’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Summit Capital Management’s Portfolio RGDX Stock Details RGDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,000
Closed -$12K – 69
2014
Q1 		$12K Buy
+10,000
New +$14K ﹤0.01% 61

Other funds holding RGDX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Summit Capital Management's RGDX Position: Q2 2014 in Review

Summit Capital Management sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q2 2014, closing a stake of 10,000 shares — an estimated $12K sold.

Summit Capital Management first reported a position in RGDX in Q1 2014 and held it in 1 quarter. The position peaked at $12K in Q1 2014. 22 funds tracked by Wall St. Rank hold RGDX as of Q2 2014.

  • Summit Capital Management reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q2 2014 after selling out during the quarter.
  • Summit Capital Management sold 10,000 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q2 2014, an estimated $12K.
  • Summit Capital Management first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q1 2014 and held it in 1 quarter.
  • Summit Capital Management's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $12K in Q1 2014.
  • 22 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q2 2014.

Based on Summit Capital Management's 13F filing for Q2 2014, filed 8 Aug 2014.